These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 20031543)

  • 21. Metabolomic analysis of rat brain by high resolution nuclear magnetic resonance spectroscopy of tissue extracts.
    Lutz NW; Béraud E; Cozzone PJ
    J Vis Exp; 2014 Sep; (91):51829. PubMed ID: 25285979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in metabolite identification.
    Wishart DS
    Bioanalysis; 2011 Aug; 3(15):1769-82. PubMed ID: 21827274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical applications of metabolomics in oncology: a review.
    Spratlin JL; Serkova NJ; Eckhardt SG
    Clin Cancer Res; 2009 Jan; 15(2):431-40. PubMed ID: 19147747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolomic profiling and genomic analysis of wheat aneuploid lines to identify genes controlling biochemical pathways in mature grain.
    Francki MG; Hayton S; Gummer JP; Rawlinson C; Trengove RD
    Plant Biotechnol J; 2016 Feb; 14(2):649-60. PubMed ID: 26032167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mass spectrometry-based metabolomics: Targeting the crosstalk between gut microbiota and brain in neurodegenerative disorders.
    Luan H; Wang X; Cai Z
    Mass Spectrom Rev; 2019 Jan; 38(1):22-33. PubMed ID: 29130504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteomics and metabolomics for mechanistic insights and biomarker discovery in cardiovascular disease.
    Barallobre-Barreiro J; Chung YL; Mayr M
    Rev Esp Cardiol (Engl Ed); 2013 Aug; 66(8):657-61. PubMed ID: 24776335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic Influences on Metabolite Levels: A Comparison across Metabolomic Platforms.
    Yet I; Menni C; Shin SY; Mangino M; Soranzo N; Adamski J; Suhre K; Spector TD; Kastenmüller G; Bell JT
    PLoS One; 2016; 11(4):e0153672. PubMed ID: 27073872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Illuminating the dark metabolome to advance the molecular characterisation of biological systems.
    Jones OAH
    Metabolomics; 2018 Jul; 14(8):101. PubMed ID: 30830382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single-platform 'multi-omic' profiling: unified mass spectrometry and computational workflows for integrative proteomics-metabolomics analysis.
    Blum BC; Mousavi F; Emili A
    Mol Omics; 2018 Oct; 14(5):307-319. PubMed ID: 30211418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolomics in chronic kidney disease: Strategies for extended metabolome coverage.
    Gagnebin Y; Julien B; Belén P; Serge R
    J Pharm Biomed Anal; 2018 Nov; 161():313-325. PubMed ID: 30195171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolomics: small molecules that matter more.
    Muthubharathi BC; Gowripriya T; Balamurugan K
    Mol Omics; 2021 Apr; 17(2):210-229. PubMed ID: 33598670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The combination of four analytical methods to explore skeletal muscle metabolomics: Better coverage of metabolic pathways or a marketing argument?
    Bruno C; Patin F; Bocca C; Nadal-Desbarats L; Bonnier F; Reynier P; Emond P; Vourc'h P; Joseph-Delafont K; Corcia P; Andres CR; Blasco H
    J Pharm Biomed Anal; 2018 Jan; 148():273-279. PubMed ID: 29059617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The role of -omics technology in the pathophysiology, diagnosis, and treatment of cardiovascular diseases].
    Sinan ÜY; Unlu S
    Turk Kardiyol Dern Ars; 2017 Jul; 45(5):470-484. PubMed ID: 28694404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Analysis of metabolomics and proteomics based on capillary electrophoresis-mass spectrometry].
    Wang F; Wang S; Cong H; Yu B
    Se Pu; 2020 Sep; 38(9):1013-1021. PubMed ID: 34213267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emerging field of metabolomics: big promise for cancer biomarker identification and drug discovery.
    Patel S; Ahmed S
    J Pharm Biomed Anal; 2015 Mar; 107():63-74. PubMed ID: 25569286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In situ metabolomic mass spectrometry imaging: recent advances and difficulties.
    Miura D; Fujimura Y; Wariishi H
    J Proteomics; 2012 Aug; 75(16):5052-5060. PubMed ID: 22366554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Metabolic profiling of human blood].
    Trifonova OP; Lokhov PG; Archakov AI
    Biomed Khim; 2014; 60(3):281-94. PubMed ID: 25019391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The evolving landscape of untargeted metabolomics.
    Di Minno A; Gelzo M; Stornaiuolo M; Ruoppolo M; Castaldo G
    Nutr Metab Cardiovasc Dis; 2021 Jun; 31(6):1645-1652. PubMed ID: 33895079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Untargeted high-resolution plasma metabolomic profiling predicts outcomes in patients with coronary artery disease.
    Mehta A; Liu C; Nayak A; Tahhan AS; Ko YA; Dhindsa DS; Kim JH; Hayek SS; Sperling LS; Mehta PK; Sun YV; Uppal K; Jones DP; Quyyumi AA
    PLoS One; 2020; 15(8):e0237579. PubMed ID: 32810196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PROMIS: Global Analysis of PROtein-Metabolite Interactions.
    Sokolowska EM; Schlossarek D; Luzarowski M; Skirycz A
    Curr Protoc Plant Biol; 2019 Dec; 4(4):e20101. PubMed ID: 31750999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.